Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________. Commission File Number: 001-39565 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 85-1 ...

AN INTRODUCTION TO BEAUTYHEALTH MARCH 2022 ♡ BEAUTYHEALTH® DISCLAIMER This Pesentation contains certain bowerardersents. These catements may ede bo, bot can ool initied by expections of hittled by expecting residencered The Beauly Health cericin lee vinancial and operating metrios, copidal expericines, the introduction at new nodels, propatision into new motels, projections of makel appotwing nat he citili stements con be identified by the use of forwardlocking world such as ' onficipats,' ' suggest," ' pho ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-04321 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 85-1908962 (State or other jurisdiction of incorporation or orga ...

4™ QUARTER 202 1 EARNINGS PRESENTATION FEBRUARY 22, 2022 ♡ BEAUTYHEALTH® DISCLAIMER This Pesentation contains certain bowerardersents. These catements may ede bo, bot can ool initied by expections of hittled by expecting residencered The Beauly Health cerican lea frinancial and qevaling makirs, rapid expendiums, the rincoludion at new radeks ond the editly re eventision into new noneboaking sphares con be italikas bothe tawardfobing vouds sud rou "anticipate," "exped," "don" "believe," "hiend," "estimates" ...

The Beauty Health Company (NASDAQ:SKIN) Q4 2021 Earnings Conference Call February 22, 2022 4:30 PM ET Company Participants Dawn Francfort – Managing Director ICR Brent Saunders – Executive Director Andrew Stanleick – President & Chief Executive Officer Liyuan Woo – Chief Financial Officer Conference Call Participants Oliver Chen – Cowen Bruce Jackson – The Benchmark Company Korinne Wolfmeyer – Piper Sandler Phil – Goldman Sachs Olivia Tong – Raymond James Jonathan Block – Stifel Maggie Boeye – William Blair ...

INVESTOR PRESENTATION NOVEMBER 2021 ♡ BEAUTYHEALTH® This Presentation contains certain forward-looking statements. These statements may relate to, but are not limited to, expectations of future operating results or financial performance of The Beauty Health Company (the "Company"), the calculation of certain key financial and operating metrics, capital expenditures, the introduction of new products, expansion into new markets and the ability to execute certain strategic initiatives. Some of the forward-look ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 Long Beach, CA 90806 (800) 603-4996 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________. Commission File Number: 001-39565 The Beauty Health Company (Exact name of registrant as ...

The Beauty Health Company (NASDAQ:SKIN) Q3 2021 Earnings Conference Call November 9, 2021 4:30 PM ET Company Participants Dawn Francfort - MD, ICR, Inc. Brent Saunders - Executive Chairman Clint Carnell - CEO Liyuan Woo - CFO Conference Call Participants Oliver Chen - Cowen & Company Steph Wissink - Jefferies Jonathan Block - Stifel Financial Corp Kyle Rose - Canaccord Linda Bolton Weiser - D.A. Davidson Operator Greetings and welcome to The Beauty Health Third Quarter 2021 Earnings Call. [Operator Instruct ...

INVESTOR PRESENTATION SEPTEMBER 2021 ♡ BEAUTYHEALTH® This Presentation contains certain forward-looking statements. These statements may relate to, but are not limited to, expectations of future operating results or financial performance of The Beauty Health Company (the "Company"), the calculation of certain key financial and operating metrics, capital expenditures, the introduction of new products, expansion into new markets and the ability to execute certain strategic initiatives. Some of the forward-loo ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to Commission file number: 001-39565 The Beauty Health Company 2165 Spring Street (Address of principal executive offices, including zip code) Registrant ...